{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T16:19:57Z","timestamp":1791821997213,"version":"4.3.4"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,20]],"date-time":"2024-08-20T00:00:00Z","timestamp":1724112000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,8,20]],"date-time":"2024-08-20T00:00:00Z","timestamp":1724112000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82160742"],"award-info":[{"award-number":["82160742"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Corps key areas of scientific and technological research program","award":["2023CB008-25"],"award-info":[{"award-number":["2023CB008-25"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-70253-5","type":"journal-article","created":{"date-parts":[[2024,8,20]],"date-time":"2024-08-20T14:04:56Z","timestamp":1724162696000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Lactucin reverses liver fibrosis by inhibiting TGF-\u03b21\/STAT3 signaling pathway and regulating short-chain fatty acids metabolism"],"prefix":"10.1038","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8406-4735","authenticated-orcid":false,"given":"Dongmei","family":"Qin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuefeng","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liping","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,20]]},"reference":[{"key":"70253_CR1","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s12916-014-0145-y","volume":"12","author":"AA Mokdad","year":"2014","unstructured":"Mokdad, A. A. et al. Liver cirrhosis mortality in 187 countries between 1980 and 2010: A systematic analysis. BMC Med. 12, 145 (2014).","journal-title":"BMC Med."},{"key":"70253_CR2","doi-asserted-by":"publisher","first-page":"958","DOI":"10.11569\/wcjd.v25.i11.958","volume":"25","author":"D Qin","year":"2017","unstructured":"Qin, D., Zhang, Y. & Li, L. Progress in research of Chinese herbal medicines with anti-hepatic fibrosis activity. World Chin. J. Digestol. 25, 958\u2013965 (2017).","journal-title":"World Chin. J. Digestol."},{"key":"70253_CR3","doi-asserted-by":"publisher","first-page":"337","DOI":"10.3350\/cmh.2012.18.4.337","volume":"18","author":"YS Seo","year":"2012","unstructured":"Seo, Y. S. & Shah, V. H. The role of gut-liver axis in the pathogenesis of liver cirrhosis and portal hypertension. Clin. Mol. Hepatol. 18, 337\u2013346 (2012).","journal-title":"Clin. Mol. Hepatol."},{"key":"70253_CR4","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.coi.2018.12.003","volume":"56","author":"F Chen","year":"2019","unstructured":"Chen, F. & Stappenbeck, T. S. Microbiome control of innate reactivity. Curr. Opin. Immunol. 56, 107\u2013113 (2019).","journal-title":"Curr. Opin. Immunol."},{"key":"70253_CR5","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/j.chom.2018.05.003","volume":"23","author":"A Agus","year":"2018","unstructured":"Agus, A., Planchais, J. & Sokol, H. Gut microbiota regulation of tryptophan metabolism in health and disease. Cell Host Microbe 23, 716\u2013724 (2018).","journal-title":"Cell Host Microbe"},{"key":"70253_CR6","doi-asserted-by":"publisher","first-page":"683613","DOI":"10.3389\/fphar.2021.683613","volume":"12","author":"C Han","year":"2021","unstructured":"Han, C. et al. Cichorium pumilum Jacq extract inhibits LPS-induced inflammation via MAPK signaling pathway and protects rats from hepatic fibrosis caused by abnormalities in the gut-liver axis. Front. Pharmacol. 12, 683613 (2021).","journal-title":"Front. Pharmacol."},{"key":"70253_CR7","doi-asserted-by":"publisher","first-page":"1972746","DOI":"10.1080\/19490976.2021.1972746","volume":"13","author":"Y Nie","year":"2021","unstructured":"Nie, Y. et al. Ursolic acid reverses liver fibrosis by inhibiting NOX4\/NLRP3 inflammasome pathways and bacterial dysbiosis. Gut Microbes 13, 1972746 (2021).","journal-title":"Gut Microbes"},{"key":"70253_CR8","first-page":"1299","volume":"38","author":"H Li","year":"2022","unstructured":"Li, H. et al. Clinical significance of the determination of fecal short - chain fatty acids in patients with nonalcoholic fatty liver disease. J. Clin. Hepatol. 38, 1299\u20131306 (2022).","journal-title":"J. Clin. Hepatol."},{"key":"70253_CR9","doi-asserted-by":"publisher","DOI":"10.4110\/in.2019.19.e9","volume":"19","author":"JW Park","year":"2019","unstructured":"Park, J. W. et al. Short-chain fatty acids inhibit staphylococcal lipoprotein-induced nitric oxide production in murine macrophages. Immune Netw. 19, e9 (2019).","journal-title":"Immune Netw."},{"key":"70253_CR10","doi-asserted-by":"publisher","first-page":"01954b","DOI":"10.1039\/D0FO01954B","volume":"11","author":"TT Yang","year":"2020","unstructured":"Yang, T. T. et al. Amelioration of non-alcoholic fatty liver disease by sodium butyrate is linked to the modulation of intestinal tight junctions in db\/db mice. Food Funct. 11, 01954b (2020).","journal-title":"Food Funct."},{"key":"70253_CR11","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.addr.2017.05.007","volume":"121","author":"SLF Takaaki Higashi","year":"2017","unstructured":"Takaaki Higashi, S. L. F. & Hoshida, Y. Hepatic stellate cells as key target in liver fibrosis. Adv. Drug Deliv. Rev. 121, 27\u201342 (2017).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"70253_CR12","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s00441-011-1246-y","volume":"347","author":"Steven Dooley PtD","year":"2012","unstructured":"Steven Dooley PtD. TGF-\u03b2 in progression of liver disease. Cell Tissue Res. 347, 245\u2013256 (2012).","journal-title":"Cell Tissue Res."},{"key":"70253_CR13","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.3390\/cells8111419","volume":"8","author":"B Dewidar","year":"2019","unstructured":"Dewidar, B., Meyer, C. & Dooley, S. TGF-\u03b2 in hepatic stellate cell activation and liver fibrogenesis - updated. Cells 8, 1419 (2019).","journal-title":"Cells"},{"key":"70253_CR14","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.matbio.2015.01.004","volume":"44\u201346","author":"S Duarte","year":"2015","unstructured":"Duarte, S., Baber, J., Fujii, T. & Coito, A. J. Matrix metalloproteinases in liver injury, repair and fibrosis. Matrix Biol. 44\u201346, 147\u2013156 (2015).","journal-title":"Matrix Biol."},{"key":"70253_CR15","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.matbio.2017.12.012","volume":"68\u201369","author":"E Roeb","year":"2018","unstructured":"Roeb, E. Matrix metalloproteinases and liver fibrosis (translational aspects). Matrix Biol. 68\u201369, 463\u2013473 (2018).","journal-title":"Matrix Biol."},{"key":"70253_CR16","first-page":"44","volume":"86","author":"KLKV Raikhelson","year":"2014","unstructured":"Raikhelson, K. L. K. V. & Marchenko, N. V. Role of transforming growth factor-beta in the development of some liver diseases. Terapevticheskii Arkhiv 86, 44\u201348 (2014).","journal-title":"Terapevticheskii Arkhiv"},{"key":"70253_CR17","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1053\/jhep.2001.28457","volume":"34","author":"DM Bissell","year":"2001","unstructured":"Bissell, D. M., Roulot, D. & George, J. Transforming growth factor beta and the liver. Hepatology 34, 859\u2013867 (2001).","journal-title":"Hepatology"},{"key":"70253_CR18","first-page":"208","volume":"40","author":"T Li","year":"2022","unstructured":"Li, T. Research progress of STAT3 on liver disease. J. Pharm. Pract. 40, 208\u2013211 (2022).","journal-title":"J. Pharm. Pract."},{"key":"70253_CR19","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1007\/s11596-020-2211-3","volume":"40","author":"G Hou","year":"2020","unstructured":"Hou, G. et al. Long ameliorates hepatic fibrosis by inhibiting PI3K\/AKT, Ras\/ERK and JAK1\/STAT3 signaling pathways in CCl4-induced liver fibrosis rats. Curr. Med. Sci. 40, 539\u2013547 (2020).","journal-title":"Curr. Med. Sci."},{"key":"70253_CR20","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.jep.2004.06.031","volume":"95","author":"TA Bischoff","year":"2004","unstructured":"Bischoff, T. A. et al. Antimalarial activity of lactucin and lactucopicrin: Sesquiterpene lactones isolated from Cichorium intybus L. J. Ethnopharmacol. 95, 455\u2013457 (2004).","journal-title":"J. Ethnopharmacol."},{"key":"70253_CR21","first-page":"540","volume":"35","author":"C Han","year":"2019","unstructured":"Han, C. et al. Study on differences in antibacterial activity of ethanol extracts from chicory roots and stems against Staphylococcus aureus and Enterococcus faecalis. Chin. Pharmacol. Bull. 35, 540\u2013545 (2019).","journal-title":"Chin. Pharmacol. Bull."},{"key":"70253_CR22","doi-asserted-by":"publisher","first-page":"331","DOI":"10.3390\/cells9020331","volume":"9","author":"X Wang","year":"2020","unstructured":"Wang, X. et al. A potential nutraceutical Candidate lactucin inhibits adipogenesis through downregulation of JAK2\/STAT3 signaling pathway-mediated mitotic clonal expansion. Cells 9, 331 (2020).","journal-title":"Cells"},{"key":"70253_CR23","doi-asserted-by":"publisher","first-page":"104170","DOI":"10.1016\/j.fitote.2019.104170","volume":"136","author":"T Dang","year":"2019","unstructured":"Dang, T. et al. Sesquiterpenoids with diverse carbon skeletons from the roots of Cichorium glandulosum and their anti-inflammatory activities. Fitoterapia 136, 104170 (2019).","journal-title":"Fitoterapia"},{"key":"70253_CR24","doi-asserted-by":"publisher","DOI":"10.5812\/ircmj.10908","volume":"15","author":"D Qin","year":"2013","unstructured":"Qin, D., Wen, Z., Nie, Y. & Yao, G. Effect of cichorium glandulosum extracts on CCl4-induced hepatic fibrosis. Iran Red Crescent Med. J. 15, e10908 (2013).","journal-title":"Iran Red Crescent Med. J."},{"key":"70253_CR25","doi-asserted-by":"publisher","first-page":"311","DOI":"10.4314\/tjpr.v18i2.13","volume":"18","author":"D Qin","year":"2019","unstructured":"Qin, D. et al. Studies on the protective effect of total flavonoids from Cichorium glandulosum roots against carbon tetrachloride-induced liver fibrosis in rats. Trop. J. Pharm. Res. 18, 311\u2013319 (2019).","journal-title":"Trop. J. Pharm. Res."},{"key":"70253_CR26","first-page":"1627","volume":"36","author":"D Hui","year":"2020","unstructured":"Hui, D. & Cheng, S. Association between nonalcoholic fatty liver disease and gut microbiota based on the theory of gut-liver axis. J. Clin. Hepatol. 36, 1627\u20131630 (2020).","journal-title":"J. Clin. Hepatol."},{"key":"70253_CR27","doi-asserted-by":"publisher","first-page":"6161","DOI":"10.3748\/wjg.v27.i37.6161","volume":"27","author":"SP Sharma","year":"2021","unstructured":"Sharma, S. P., Suk, K. T. & Kim, D. J. Significance of gut microbiota in alcoholic and non-alcoholic fatty liver diseases. World J. Gastroenterol. 27, 6161\u20136179 (2021).","journal-title":"World J. Gastroenterol."},{"key":"70253_CR28","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1017\/S0029665114001463","volume":"74","author":"HJ Flint","year":"2015","unstructured":"Flint, H. J., Duncan, S. H., Scott, K. P. & Louis, P. Links between diet, gut microbiota composition and gut metabolism. Proc. Nutr. Soc. 74, 13\u201322 (2015).","journal-title":"Proc. Nutr. Soc."},{"key":"70253_CR29","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1101\/gad.284091.116","volume":"30","author":"M Levy","year":"2016","unstructured":"Levy, M., Thaiss, C. A. & Elinav, E. Metabolites: Messengers between the microbiota and the immune system. Genes Dev. 30, 1589\u20131597 (2016).","journal-title":"Genes Dev."},{"key":"70253_CR30","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1038\/ncomms2852","volume":"4","author":"I Kimura","year":"2013","unstructured":"Kimura, I. et al. The gut microbiota suppresses insulin-mediated fat accumulation via the short-chain fatty acid receptor GPR43. Nat. Commun. 4, 1829 (2013).","journal-title":"Nat. Commun."},{"key":"70253_CR31","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/j.coph.2013.08.006","volume":"13","author":"V Ganapathy","year":"2013","unstructured":"Ganapathy, V., Thangaraju, M., Prasad, P. D., Martin, P. M. & Singh, N. Transporters and receptors for short-chain fatty acids as the molecular link between colonic bacteria and the host. Curr. Opin. Pharmacol. 13, 869\u2013874 (2013).","journal-title":"Curr. Opin. Pharmacol."},{"key":"70253_CR32","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/nrgastro.2016.85","volume":"13","author":"C Leung","year":"2016","unstructured":"Leung, C., Rivera, L., Furness, J. B. & Angus, P. W. The role of the gut microbiota in NAFLD. Nat. Rev. Gastroenterol. Hepatol. 13, 412\u2013425 (2016).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"70253_CR33","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20190489","author":"JL Fachi","year":"2020","unstructured":"Fachi, J. L. et al. Acetate coordinates neutrophil and ILC3 responses against C. difficile through FFAR2. J. Exp. Med. https:\/\/doi.org\/10.1084\/jem.20190489 (2020).","journal-title":"J. Exp. Med."},{"key":"70253_CR34","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.1053\/j.gastro.2010.02.049","volume":"138","author":"M Mair","year":"2010","unstructured":"Mair, M. et al. Signal transducer and activator of transcription 3 protects from liver injury and fibrosis in a mouse model of sclerosing cholangitis. Gastroenterology 138, 2499\u20132508 (2010).","journal-title":"Gastroenterology"},{"key":"70253_CR35","doi-asserted-by":"publisher","first-page":"88","DOI":"10.3109\/08977194.2012.660936","volume":"30","author":"H Kiu","year":"2012","unstructured":"Kiu, H. & Nicholson, S. E. Biology and significance of the JAK\/STAT signalling pathways. Growth Factors 30, 88\u2013106 (2012).","journal-title":"Growth Factors"},{"key":"70253_CR36","doi-asserted-by":"publisher","first-page":"7243","DOI":"10.1073\/pnas.1507499112","volume":"112","author":"TH Su","year":"2015","unstructured":"Su, T. H. et al. Sorafenib and its derivative SC-1 exhibit antifibrotic effects through signal transducer and activator of transcription 3 inhibition. Proc. Natl. Acad. Sci. U. S. A. 112, 7243\u20137248 (2015).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"70253_CR37","doi-asserted-by":"publisher","first-page":"3555","DOI":"10.1038\/s41467-018-05901-2","volume":"9","author":"M Sun","year":"2018","unstructured":"Sun, M. et al. Microbiota-derived short-chain fatty acids promote Th1 cell IL-10 production to maintain intestinal homeostasis. Nat. Commun. 9, 3555 (2018).","journal-title":"Nat. Commun."},{"key":"70253_CR38","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.jep.2005.03.027","volume":"100","author":"Y Chen","year":"2005","unstructured":"Chen, Y., Li, D. G., Wu, J., Chen, Y. & Lu, H. Tetrandrine inhibits activation of rat hepatic stellate cells stimulated by transforming growth factor-beta in vitro via up-regulation of Smad 7. J. Ethnopharmacol. 100, 299\u2013305 (2005).","journal-title":"J. Ethnopharmacol."},{"key":"70253_CR39","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1093\/toxsci\/kfv081","volume":"146","author":"X Tu","year":"2015","unstructured":"Tu, X. et al. MicroRNA-30 protects against carbon tetrachloride-induced liver fibrosis by attenuating transforming growth factor beta signaling in hepatic stellate cells. Toxicol. Sci. 146, 157\u2013169 (2015).","journal-title":"Toxicol. Sci."},{"key":"70253_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1749-6632.2003.tb03205.x","volume":"995","author":"AB Roberts","year":"2003","unstructured":"Roberts, A. B., Russo, A., Felici, A. & Flanders, K. C. Smad3: A key player in pathogenetic mechanisms dependent on TGF-beta. Ann. N. Y. Acad. Sci. 995, 1\u201310 (2003).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"70253_CR41","first-page":"1012","volume":"10","author":"Z Hu","year":"2018","unstructured":"Hu, Z. et al. Paeoniflorin exerts protective effect on radiation-induced hepatic fibrosis in rats via TGF-beta1\/Smads signaling pathway. Am. J. Transl. Res. 10, 1012\u20131021 (2018).","journal-title":"Am. J. Transl. Res."},{"key":"70253_CR42","first-page":"879","volume":"17","author":"D Qin","year":"2014","unstructured":"Qin, D., Nie, Y. & Wen, Z. Protection of rats from thioacetamide-induced hepatic fibrosis by the extracts of a traditional Uighur medicine Cichorium glandulosum, Iran J Basic. Med. Sci. 17, 879\u2013885 (2014).","journal-title":"Med. Sci."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-70253-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-70253-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-70253-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,20]],"date-time":"2024-08-20T14:10:09Z","timestamp":1724163009000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-70253-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,20]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["70253"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-70253-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4288774\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,20]]},"assertion":[{"value":"18 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"19323"}}